T1	CHEM 4 13	glutamina
#1	AnnotatorNotes T1	C0017797; glutamine; Amino Acid, Peptide, or Protein · Biologically Active Substance · Pharmacologic Substance
T2	PROC 578 607	marcadores de lesión cardiaca
T3	PROC 330 357	marcadores de daño cardiaco
T4	DISO 29 44	daño miocárdico
T5	PROC 50 77	revascularización coronaria
#2	AnnotatorNotes T5	C0877341; Coronary revascularisation; Therapeutic or Preventive Procedure
T6	PROC 83 108	derivación cardiopulmonar
#3	AnnotatorNotes T6	C0007202; Cardiopulmonary Bypass; Therapeutic or Preventive Procedure
T7	PROC 789 806	asignados al azar
#4	AnnotatorNotes T7	C0034656; Randomization; Research Activity
T8	CHEM 160 169	glutamina
#5	AnnotatorNotes T8	C0017797; glutamine; Amino Acid, Peptide, or Protein · Biologically Active Substance · Pharmacologic Substance
T9	CHEM 176 186	aminoácido
#6	AnnotatorNotes T9	C0002520; Amino Acids; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Biologically Active Substance
T10	ANAT 213 219	cuerpo
#7	AnnotatorNotes T10	C0460148; Human body structure; Anatomical Structure | C1318419; Entire human body; Anatomical Structure
T11	ANAT 238 247	celulares
#8	AnnotatorNotes T11	C0007634; Cells; Cell | C1269647; Entire cell; Cell
T12	PROC 1060 1089	niveles séricos de marcadores
T13	ANAT 349 357	cardiaco
#9	AnnotatorNotes T13	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T14	CHEM 392 401	glutamina
#10	AnnotatorNotes T14	C0017797; glutamine; Amino Acid, Peptide, or Protein · Biologically Active Substance · Pharmacologic Substance
T15	PROC 430 444	estudio piloto
#11	AnnotatorNotes T15	C0031928; Pilot Projects; Research Activity
T16	CHEM 522 531	glutamina
#12	AnnotatorNotes T16	C0017797; glutamine; Amino Acid, Peptide, or Protein · Biologically Active Substance · Pharmacologic Substance
T17	PROC 504 518	suplementación
#13	AnnotatorNotes T17	C0242297; Dietary Supplementation; Therapeutic or Preventive Procedure
T18	ANAT 599 607	cardiaca
#14	AnnotatorNotes T18	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T19	DISO 679 700	cardiopatía isquémica
#15	AnnotatorNotes T19	C0151744; Myocardial Ischemia; Disease or Syndrome
T20	PROC 715 736	bypass cardiopulmonar
#16	AnnotatorNotes T20	C0007202; Cardiopulmonary Bypass; Therapeutic or Preventive Procedure
T21	ANAT 722 736	cardiopulmonar
#17	AnnotatorNotes T21	C0553534; Cardiopulmonary; Body Location or Region
T22	PROC 741 766	circulación extracorpórea
#18	AnnotatorNotes T22	C0015354; Extracorporeal Circulation; Therapeutic or Preventive Procedure
T23	CHEM 820 829	glutamina
#19	AnnotatorNotes T23	C0017797; glutamine; Amino Acid, Peptide, or Protein · Biologically Active Substance · Pharmacologic Substance
T24	CHEM 852 865	maltodextrina
#20	AnnotatorNotes T24	C0065601; maltodextrin; Organic Chemical · Pharmacologic Substance
T25	PROC 886 894	operados
#21	AnnotatorNotes T25	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T26	PROC 912 935	creatinina fosfoquinasa
#22	AnnotatorNotes T26	C0750860; Serum creatine phosphokinase; Laboratory Procedure (?) | C0201973; Creatine kinase measurement; Laboratory Procedure (?)
T27	PROC 938 964	creatinina fosfoquinasa-Mb
#23	AnnotatorNotes T27	C0858332; Serum creatine phosphokinase MB; Laboratory Procedure (?) | C0523584; Creatine kinase MB measurement; Laboratory Procedure (?)
T28	ANAT 1068 1075	séricos
#24	AnnotatorNotes T28	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T29	CHEM 1120 1129	glutamina
#25	AnnotatorNotes T29	C0017797; glutamine; Amino Acid, Peptide, or Protein · Biologically Active Substance · Pharmacologic Substance
T30	DISO 1244 1258	complicaciones
#26	AnnotatorNotes T30	C0009566; Complication; Pathologic Function
T31	CHEM 1289 1298	glutamina
#27	AnnotatorNotes T31	C0017797; glutamine; Amino Acid, Peptide, or Protein · Biologically Active Substance · Pharmacologic Substance
T32	DISO 1437 1459	tromboembolia pulmonar
#28	AnnotatorNotes T32	C0034065; Pulmonary Embolism; Pathologic Function | C0524702; Pulmonary Thromboembolisms; Disease or Syndrome
T33	CHEM 1475 1484	glutamina
#29	AnnotatorNotes T33	C0017797; glutamine; Amino Acid, Peptide, or Protein · Biologically Active Substance · Pharmacologic Substance
T34	CHEM 1546 1555	glutamina
#30	AnnotatorNotes T34	C0017797; glutamine; Amino Acid, Peptide, or Protein · Biologically Active Substance · Pharmacologic Substance
T35	PROC 1696 1735	niveles séricos de marcadores cardiacos
#31	AnnotatorNotes T35	C1271630; Cardiac markers; Laboratory Procedure
T36	DISO 1660 1675	daño miocárdico
T37	ANAT 1704 1711	séricos
#32	AnnotatorNotes T37	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T38	ANAT 1726 1735	cardiacos
#33	AnnotatorNotes T38	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T39	CHEM 1811 1820	glutamina
#34	AnnotatorNotes T39	C0017797; glutamine; Amino Acid, Peptide, or Protein · Biologically Active Substance · Pharmacologic Substance
T40	ANAT 34 44	miocárdico
#35	AnnotatorNotes T40	C0027061; Myocardium; Tissue | C1284309; Entire myocardium; Tissue
T41	ANAT 68 77	coronaria
#36	AnnotatorNotes T41	C0205042; Coronary artery; Body Part, Organ, or Organ Component | C1269008; Entire coronary artery; Body Part, Organ, or Organ Component
T42	ANAT 94 108	cardiopulmonar
#37	AnnotatorNotes T42	C0553534; Cardiopulmonary; Body Location or Region
T43	PROC 113 140	ensayo clínico aleatorizado
#38	AnnotatorNotes T43	C0206034; Clinical Trials, Randomized; Research Activity
T44	DISO 344 357	daño cardiaco
#39	AnnotatorNotes T44	C1391976; lesion; cardiac; Disease or Syndrome
T45	DISO 592 607	lesión cardiaca
#40	AnnotatorNotes T45	C1391976; lesion; cardiac; Disease or Syndrome
T46	PROC 620 647	ensayo clínico aleatorizado
#41	AnnotatorNotes T46	C0206034; Clinical Trials, Randomized; Research Activity
T47	PROC 899 910	troponina-I
#42	AnnotatorNotes T47	C0920210; Troponin I measurement; Laboratory Procedure
T48	DISO 1381 1404	falla orgánica múltiple
#43	AnnotatorNotes T48	C0026766; Multiple Organ Failure; Pathologic Function
T49	ANAT 1451 1459	pulmonar
#44	AnnotatorNotes T49	C0034052; Pulmonary artery structure; Body Part, Organ, or Organ Component | C1269026; Entire pulmonary artery; Body Part, Organ, or Organ Component
T50	PROC 1514 1528	administración
#45	AnnotatorNotes T50	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T51	ANAT 1665 1675	miocárdico
#46	AnnotatorNotes T51	C0027061; Myocardium; Tissue | C1284309; Entire myocardium; Tissue
T52	Route 14 18	oral
#47	AnnotatorNotes T52	C1527415; Oral Route of Drug administration; Functional Concept
T53	LIVB 361 370	pacientes
#48	AnnotatorNotes T53	C0030705; Patients; Patient or Disabled Group
T54	Route 402 413	intravenosa
#49	AnnotatorNotes T54	C1522726; Intravenous Route of Drug Administration; Functional Concept
T55	Route 419 423	oral
#50	AnnotatorNotes T55	C1527415; Oral Route of Drug administration; Functional Concept
T56	Date 486 499	preoperatorio
#51	AnnotatorNotes T56	C0445204; Preoperative; Temporal Concept | C2712277; Preoperative Period; Temporal Concept
T57	Route 532 536	oral
#52	AnnotatorNotes T57	C1527415; Oral Route of Drug administration; Functional Concept
T58	Time 555 570	postoperatorios
#53	AnnotatorNotes T58	C0032790; Postoperative Period; Temporal Concept
T59	LIVB 655 664	pacientes
#54	AnnotatorNotes T59	C0030705; Patients; Patient or Disabled Group
T60	LIVB 772 781	pacientes
#55	AnnotatorNotes T60	C0030705; Patients; Patient or Disabled Group
T61	Route 830 834	oral
#56	AnnotatorNotes T61	C1527415; Oral Route of Drug administration; Functional Concept
T62	Dose 836 844	0,5 g/kg
T63	Frequency 844 848	/día
T64	Duration 866 872	3 días
T65	Duration 982 1020	la hora, 12 y 24 horas postoperatorias
T69	Duration 1038 1055	las 12 y 24 horas
T70	LIVB 1411 1424	grupo control
#57	AnnotatorNotes T70	C0009932; Control Groups; Group
T71	Route 1556 1560	oral
#58	AnnotatorNotes T71	C1527415; Oral Route of Drug administration; Functional Concept
T72	Date 1571 1584	preoperatoria
#59	AnnotatorNotes T72	C0445204; Preoperative; Temporal Concept | C2712277; Preoperative Period; Temporal Concept
T73	Dose 1586 1594	0,5 g/kg
T74	Frequency 1594 1598	/día
T75	Time 1676 1690	postoperatorio
#60	AnnotatorNotes T75	C0032790; Postoperative Period; Temporal Concept
T76	LIVB 1786 1795	pacientes
#61	AnnotatorNotes T76	C0030705; Patients; Patient or Disabled Group
T77	PHYS 228 261	funciones celulares inmunológicas
#62	AnnotatorNotes T77	C0301880; Cellular immunologic competence; Cell Function
T66	LIVB 1148 1157	controles
#63	AnnotatorNotes T66	C0009932; Control Groups; Group
T67	DISO 1343 1353	mortalidad
#64	AnnotatorNotes T67	C1306577; Death (finding); Finding | C1546956; Patient Outcome - Died; Finding
R1	Has_Route_or_Mode Arg1:T1 Arg2:T52	
R2	Location_of Arg1:T40 Arg2:T4	
R4	After Arg1:T4 Arg2:T5	
R5	Location_of Arg1:T41 Arg2:T5	
R6	Location_of Arg1:T42 Arg2:T6	
R7	Combined_with Arg1:T5 Arg2:T6	
R8	Location_of Arg1:T10 Arg2:T8	
R9	Location_of Arg1:T10 Arg2:T9	
R10	Location_of Arg1:T11 Arg2:T77	
R11	Location_of Arg1:T13 Arg2:T44	
R13	Experiences Arg1:T53 Arg2:T3	
R14	Experiences Arg1:T53 Arg2:T44	
R15	Has_Route_or_Mode Arg1:T14 Arg2:T54	
R16	Has_Route_or_Mode Arg1:T14 Arg2:T55	
R17	Experiences Arg1:T53 Arg2:T14	
T79	Observation 479 485	efecto
#67	AnnotatorNotes T79	C1518681; Outcome of Therapy; Finding (?)
R20	Overlap Arg1:T79 Arg2:T56	
R21	Used_for Arg1:T16 Arg2:T17	
R22	Has_Route_or_Mode Arg1:T16 Arg2:T57	
R23	Causes Arg1:T17 Arg2:T79	
R24	Location_of Arg1:T18 Arg2:T45	
R26	Overlap Arg1:T2 Arg2:T58	
R28	Experiences Arg1:T59 Arg2:T19	
R29	Experiences Arg1:T59 Arg2:T20	
R30	Location_of Arg1:T21 Arg2:T20	
R31	Overlap Arg1:T20 Arg2:T22	
R32	Experiences Arg1:T59 Arg2:T22	
R33	Experiences Arg1:T60 Arg2:T23	
R34	Has_Route_or_Mode Arg1:T23 Arg2:T61	
R35	Before Arg1:T7 Arg2:T23	
R36	Before Arg1:T7 Arg2:T24	
R37	Has_Duration_or_Interval Arg1:T24 Arg2:T64	
R39	Before Arg1:T24 Arg2:T25	
R40	Before Arg1:T23 Arg2:T25	
R41	Has_Duration_or_Interval Arg1:T23 Arg2:T64	
R42	Has_Dose_or_Strength Arg1:T23 Arg2:T62	
R43	Has_Frequency Arg1:T23 Arg2:T63	
R44	Experiences Arg1:T60 Arg2:T24	
R45	Overlap Arg1:T47 Arg2:T65	
R46	Overlap Arg1:T26 Arg2:T65	
R47	Overlap Arg1:T27 Arg2:T65	
R48	Overlap Arg1:T12 Arg2:T69	
R49	Location_of Arg1:T28 Arg2:T12	
R51	Experiences Arg1:T66 Arg2:T12	
R52	Before Arg1:T31 Arg2:T30	
R53	Experiences Arg1:T70 Arg2:T67	
R54	Experiences Arg1:T70 Arg2:T48	
R55	Location_of Arg1:T49 Arg2:T32	
R56	Before Arg1:T33 Arg2:T32	
R57	Used_for Arg1:T34 Arg2:T50	
R58	Has_Route_or_Mode Arg1:T34 Arg2:T71	
R59	Overlap Arg1:T34 Arg2:T72	
R60	Has_Dose_or_Strength Arg1:T34 Arg2:T73	
R61	Has_Frequency Arg1:T34 Arg2:T74	
R62	Location_of Arg1:T51 Arg2:T36	
R63	Overlap Arg1:T36 Arg2:T75	
R65	Location_of Arg1:T37 Arg2:T35	
T81	Observation 1740 1750	morbilidad
#69	AnnotatorNotes T81	C0026538; Morbidity - disease rate; Finding
R12	Experiences Arg1:T76 Arg2:T81	
R25	Experiences Arg1:T76 Arg2:T39	
R66	Experiences Arg1:T76 Arg2:T35	
T82	CONC 1753 1763	mortalidad
#70	AnnotatorNotes T82	C0085556; Hospital Mortality; Qualitative Concept
R67	Before Arg1:T39 Arg2:T81	
R3	Experiences Arg1:T60 Arg2:T25	
R18	Before Arg1:T48 Arg2:T67	
R19	Before Arg1:T32 Arg2:T67	
#65	AnnotatorNotes T4	C0577812; Myocardial lesion; Finding
#66	AnnotatorNotes T36	C0577812; Myocardial lesion; Finding
A1	Experiencer T66 Patient
A2	Experiencer T53 Patient
A3	Experiencer T59 Patient
A4	Experiencer T60 Patient
A5	Experiencer T70 Patient
A6	Experiencer T76 Patient
